NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
11.53
+0.39 (3.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $344.15 million as of December 20, 2024. Its market cap has increased by 54.22% in one year.
Market Cap
344.15M
Enterprise Value
360.82M
1-Year Change
54.22%
Ranking
Category
Stock Price
$11.53
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $344.15M, a decrease of -12.49%. That is a compound annual growth rate of -3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 344.15M | 27.00% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 336.66M |
| Aquestive Therapeutics | 334.17M |
| Neurogene | 331.27M |
| Olema Pharmaceuticals | 330.38M |
| Eton Pharmaceuticals | 330.05M |
| Spok Holdings | 325.98M |
| Revance Therapeutics | 323.10M |
| AirSculpt Technologies | 322.00M |